Details of the Drug | DrugMAP

General Information of Drug (ID: DMI4HWK)

Drug Name

LY03005

Indication

Disease Entry	ICD 11	Status	REF
Depression	6A70-6A7Z	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C24H31NO3
Canonical SMILES: CC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(CN(C)C)C3(CCCCC3)O
InChI: 1S/C24H31NO3/c1-18-7-9-20(10-8-18)23(26)28-21-13-11-19(12-14-21)22(17-25(2)3)24(27)15-5-4-6-16-24/h7-14,22,27H,4-6,15-17H2,1-3H3
InChIKey: QKYBZJLEMOZFFU-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 15983287
CAS Number: 916918-80-4
TTD ID: D0WL3H

References

1	ClinicalTrials.gov (NCT04853407) A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD). U.S. National Institutes of Health.